C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: Incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease

Clinical Chemistry

Volumn 47, Issue 4, 2001, Pages 661-666

  Hanson, N Q ^a   Aras, O ^a   Yang, F ^a   Tsai, M Y ^a  

^a Mayo Mail Code 609   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE; METHIONINE;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; DNA POLYMORPHISM; FEMALE; FLUOROMETRY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; VASCULAR DISEASE;

EID: 0035057410     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.4.661     Document Type: Article

References (27)

1. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
2. Hyperhomocysteinemia: An independent risk factor for vascular disease
3. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
4. Serum total homocysteine and coronary heart disease
5. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
6. Methionine intolerance with normal fasting total plasma homocysteine: Initial results from the NHLBI Family Heart Study
7. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
8. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
9. Hyperhomocysteinemia and venous thromboembolic disease
10. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
11. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
12. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
13. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
14. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in the US physicians
15. Methylenetetrahydrofolate reductase gene and coronary artery disease
16. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
17. The 677 C→T mutation in the methylenetetrahydrofolate reductase gene: Associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease
18. 20210 mutation
19. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients
20. 506)
21. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis
22. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neuraltube defects?
23. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
24. Methylenetetrahydrofolate reductase (MTHFR): The incidence of mutations C677T end A1298C in the Ashkenazi Jewish population
25. Linkage disequiribrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD)
26. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum
27. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations